SAFETY
Clinical trials for SAFETY explained in plain language.
Never miss a new study
Get alerted when new SAFETY trials appear
Sign up with your email to follow new studies for SAFETY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for pregnant women launches in congo
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 359 pregnant and postpartum women in the Democratic Republic of the Congo. Some women receive the vaccine during pregnancy, others right after giving birth, and a small group gets it as an emergency sho…
Matched conditions: SAFETY
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 04:17 UTC
-
Lupus patients may benefit from engineered immune cells in early trial
Disease control TerminatedThis early-stage study tests a new treatment called RD06-04, which uses a patient's own immune cells modified to target lupus. The goal is to check safety and find the right dose in 12 adults with moderate to severe lupus who have not responded well to standard treatments. Partic…
Matched conditions: SAFETY
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Wrist artery approach for heart procedures under review in 3,600 patients
Knowledge-focused OngoingThis study is collecting information from 3,600 adults who need heart tests or treatments. Doctors will use a small artery in the wrist instead of the groin. The goal is to see how often the procedure works and if there are any problems.
Matched conditions: SAFETY
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
12,000 koreans monitored for vaccine side effects over 6 years
Knowledge-focused OngoingThis study is tracking the safety of the BNT162b2 COVID-19 vaccine (including the bivalent version) in 12,000 people in Korea who received the vaccine as part of routine care. Researchers are collecting information on side effects that happen within a week and up to 28 days after…
Matched conditions: SAFETY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC